Medpace Holdings, Inc. Increase Decrease In Operating Lease Liability
Medpace Holdings, Inc. (MEDP) reported Increase Decrease In Operating Lease Liability of -$12.36 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-07-23
- Medpace Holdings, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$7.06M.
- Medpace Holdings, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$5.29M.
- Medpace Holdings, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$7.03M.
- Medpace Holdings, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$5.52M.
- Medpace Holdings, Inc. increase decrease in operating lease liability for fiscal 2025 was -$25.16M.
- Medpace Holdings, Inc. increase decrease in operating lease liability for fiscal 2024 was -$21.41M.
- Medpace Holdings, Inc. increase decrease in operating lease liability for fiscal 2023 was -$18.87M.
- Medpace Holdings, Inc. increase decrease in operating lease liability for fiscal 2022 was -$15.90M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | -$12.36M 10-Q · filed 2026-07-23 | -$19.39M derived: sum of 3 quarters · filed 2026-07-23 | -$24.90M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | -$5.29M 10-Q · filed 2026-04-23 | -$12.32M derived: sum of 2 quarters · filed 2026-04-23 | -$17.84M derived: sum of 3 quarters · filed 2026-04-23 | -$23.91M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | -$7.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$12.54M derived: sum of 2 quarters · filed 2026-02-10 | -$18.61M derived: sum of 3 quarters · filed 2026-07-23 | -$25.16M 10-K · filed 2026-02-10 |
| 2025-09-30 | -$5.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | -$11.58M derived: sum of 2 quarters · filed 2026-07-23 | -$18.13M 10-Q · filed 2025-10-23 | -$24.12M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | -$6.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | -$12.62M 10-Q · filed 2026-07-23 | -$18.61M derived: sum of 3 quarters · filed 2026-07-23 | -$23.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | -$6.55M 10-Q · filed 2026-04-23 | -$12.54M derived: sum of 2 quarters · filed 2026-04-23 | -$16.93M derived: sum of 3 quarters · filed 2026-04-23 | -$22.01M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | -$5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$10.38M derived: sum of 2 quarters · filed 2026-02-10 | -$15.46M derived: sum of 3 quarters · filed 2026-02-10 | -$21.41M 10-K · filed 2026-02-10 |
| 2024-09-30 | -$4.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | -$9.47M derived: sum of 2 quarters · filed 2025-10-23 | -$15.42M 10-Q · filed 2025-10-23 | -$19.86M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | -$5.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | -$11.03M 10-Q · filed 2025-07-22 | -$15.46M derived: sum of 3 quarters · filed 2026-02-10 | -$20.52M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | -$5.95M 10-Q · filed 2025-04-22 | -$10.39M derived: sum of 2 quarters · filed 2026-02-10 | -$15.44M derived: sum of 3 quarters · filed 2026-02-10 | -$19.54M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | -$4.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$9.49M derived: sum of 2 quarters · filed 2026-02-10 | -$13.59M derived: sum of 3 quarters · filed 2026-02-10 | -$18.87M 10-K · filed 2026-02-10 |
| 2023-09-30 | -$5.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-22 | -$9.15M derived: sum of 2 quarters · filed 2024-10-22 | -$14.43M 10-Q · filed 2024-10-22 | |
| 2023-06-30 | -$4.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-23 | -$9.38M 10-Q · filed 2024-07-23 | ||
| 2023-03-31 | -$5.28M 10-Q · filed 2024-04-23 | |||
| 2022-12-31 | -$15.90M 10-K · filed 2025-02-11 | |||
| 2021-12-31 | -$15.63M 10-K · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |